清醒开颅术治疗癫痫性胶质瘤:术中与术后癫痫控制及预后因素
该回顾性研究分析41例癫痫性胶质瘤患者接受清醒开颅术,3例(7.3%)出现术中癫痫但未导致手术失败;14例(34.1%)出现早期术后癫痫,住院时间更长(P=0.03);33例(80.5%)在6个月时实现晚期无癫痫发作;早期癫痫复发(OR=30.75;P=0.039)与术后mRS≥3(OR=7.00;P=0.047)是晚期癫痫的独立危险因素。
要点
- 41例中3例(7.3%)出现术中癫痫,但未导致清醒开颅术失败
- 14例(34.1%)出现早期术后癫痫,住院时间较无早期癫痫者更长(P=0.03)
- 早期癫痫复发(OR=30.75;P=0.039)与术后mRS≥3(OR=7.00;P=0.047)是晚期癫痫的独立危险因素
核心结论
- 清醒开颅术中的癫痫发作可以得到良好控制。
- 早期术后癫痫延长住院时间,并强烈预测晚期癫痫复发。
- 清醒开颅术有利于癫痫性胶质瘤患者的长期癫痫控制。
研究设计与样本
- 回顾性分析41例因癫痫性胶质瘤接受清醒开颅术的患者。
- 术后癫痫定义为早期(术后第7天及之前)或晚期(术后第7天之后)发作。
- 神经功能采用改良Rankin量表(mRS)评估,癫痫结局采用国际抗癫痫联盟(ILAE)分类评估。
- 采用多变量逻辑回归分析与术后癫痫相关的临床变量。
主要发现
- 3例(7.3%)出现术中癫痫,但未导致清醒开颅术失败。
- 清醒开颅术前后平均mRS分别为2.4和2.1(P=0.032)。
- 14例(34.1%)出现早期癫痫,其住院时间较无早期癫痫者更长(P=0.03)。
- 与IDH1野生型肿瘤相比,对异柠檬酸脱氢酶1(IDH1)突变肿瘤行手术切除带来更好的术后癫痫控制。
- 33例(80.5%)在6个月时实现晚期无癫痫发作;早期癫痫复发(OR=30.75;P=0.039)和术后mRS≥3(OR=7.00;P=0.047)是晚期癫痫的独立危险因素。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Awake craniotomy is well-established for tumors resected in eloquent brain areas. Whether awake craniotomy provides improved seizure control in patients with epileptic gliomas has not been well evaluated. This study analyzed the incidence, risk factors and outcome of seizures during and following awake craniotomies for patients presenting with epilepsy and glioma. METHODS: Forty-one patients undergoing awake craniotomies for epileptic gliomas were retrospectively analyzed. Postoperative seizure was defined as either early (postoperative day 7 + before) or late onset (after postoperative day 7). Neurologic function was assessed with modified Rankin Scales (mRS) and seizure outcome was assessed using International League Against Epilepsy (ILAE) classification. Multivariable logistic regression was used for clinical variables associated with postoperative seizures. RESULTS: Three patients (7.3%) had intraoperative seizures however did not fail the awake craniotomies. Mean mRS before and after the awake craniotomies were 2.4 and 2.1, respectively (P = 0.032). Fourteen (34.1%) patients had early seizures, which caused longer hospitalization than those without early seizures (P = 0.03). Surgical resection to isocitrate dehydrogenase 1 (IDH1) mutation tumors, comparing to IDH1 wild type tumors, caused better postoperative seizure control. 6-month late seizure freedom was achieved in 33 patients (80.5%). Early seizure recurrence (odds ratio = 30.75; P = 0.039) and postoperative mRS ≥ 3 (odds ratio = 7.00; P = 0.047) were independent risk factors for late seizures. CONCLUSIONS: Intraoperative seizures could be well-controlled during awake craniotomies. Early postoperative seizures extended hospitalization and strongly predicted late seizure recurrence. Awake craniotomies benefited long-term seizure control in patients with epileptic gliomas.
引用
- Wang YC, Lee CC, Takami H, et al. Awake craniotomies for epileptic gliomas: intraoperative and postoperative seizure control and prognostic factors. J Neurooncol. 2019. PMID: 30805752. doi:10.1007/s11060-019-03131-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。